Gennext Diagnostics & Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 4.58 Cr
as on 17-12-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.55 Cr
as on 17-12-2024
- Revenue -36.33%
(FY 2022)
- Profit -3166.22%
(FY 2022)
- Ebitda -59.94%
(FY 2022)
- Net Worth -19.68%
(FY 2022)
- Total Assets 10.34%
(FY 2022)
About Gennext Diagnostics & Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.58 Cr.
The company currently has active open charges totaling ₹8.55 Cr.
Nandita Mehta, Lovi Padha, Nittin Vermani, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U85320JK2017PTC009938
- Company No.
009938
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2017
- Date of AGM
15 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Gennext Diagnostics & Research?
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nittin Vermani  | Director | 10-Sep-2023 | Current |
| Nandita Mehta | Director | 23-Dec-2019 | Current |
| Lovi Padha | Director | 23-Dec-2019 | Current |
| Abdul Salaria | Director | 25-May-2018 | Current |
| Ravinder Gupta | Director | 25-May-2018 | Current |
| Anil Gupta | Director | 09-Dec-2023 | Current |
Financial Performance of Gennext Diagnostics & Research.
Gennext Diagnostics & Research Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 36.33% decrease. The company also saw a substantial fall in profitability, with a 3166.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gennext Diagnostics & Research?
In 2020, Gennext Diagnostics & Research had a promoter holding of 11.48% and a public holding of 88.52%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Satish Mehta Clinic And Research Centre Private LimitedActive 27 years 4 monthsNandita Mehta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Jan 2022 | ₹5.50 M | Open |
Others Creation Date: 31 Aug 2021 | ₹2.00 Cr | Open |
Others Creation Date: 20 Sep 2017 | ₹6.00 Cr | Open |
How Many Employees Work at Gennext Diagnostics & Research?
Gennext Diagnostics & Research has a workforce of 27 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gennext Diagnostics & Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gennext Diagnostics & Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
